BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2582228)

  • 1. Perturbation of fibrinolysis inhibitors in progressive systemic sclerosis.
    Rothschild B; Thompson LD; Chesney M; Pifer D
    Med Hypotheses; 1985 Mar; 16(3):253-60. PubMed ID: 2582228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
    Nakamura K; Kazama M
    Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
    [No Abstract]   [Full Text] [Related]  

  • 3. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
    Rothschild BM; Thompson LD; Pifer DD; Chesney CM
    Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of local fibrinolysis in abortion.
    Ikeuchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of fibrinolysis in saliva after oral surgery measured by enzymic and immunological methods.
    Gersel-Pedersen N
    Int J Oral Surg; 1979 Jun; 8(3):212-21. PubMed ID: 93090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy].
    Laursen B; Herbst TV; Ewald EC; Pedersen SC
    Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism].
    Panchenko VM; Vladimirova AV; Pastorova VE; Sukhanova SA
    Lab Delo; 1980; (11):671-5. PubMed ID: 6160300
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitors of coagulation and fibrinolysis in diabetics].
    Tóthová E; Mechír J; Mudronová B; Petrásová D
    Vnitr Lek; 1988 Jun; 34(6):558-63. PubMed ID: 2457985
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis and antithrombin in acute leukaemia.
    Laursen B
    Dan Med Bull; 1976 May; 23(2):81-6. PubMed ID: 59658
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS).
    Maeda M; Kachi H; Mori S
    J Dermatol Sci; 1996 Mar; 11(3):223-7. PubMed ID: 8785174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of endogenous fibrinolysis activation on human plasminogen].
    Platonova TK; Kalashnikov VV; Khvatov VB
    Biull Eksp Biol Med; 1987 Jan; 103(1):59-61. PubMed ID: 2432967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis and the bleeding tendency in patients with hepatosplenic schistosomiasis.
    Omran SA; Hussein NA; Mohamed AA; el-Kaliouby AH; Hussein AT
    J Clin Pathol; 1990 Jun; 43(6):476-8. PubMed ID: 1696289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolysis and the cold pressor test].
    Quartarone M; Di Cesare E; Saitta A; Cucinotta D; Coppolino E; Squadrito G
    Boll Soc Ital Cardiol; 1978; 23(2):412-21. PubMed ID: 89853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
    Yoshimura R; Satake K
    Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlations between platelet aggregation and plasma proteins in athero-arteriosclerotic disease].
    Nocerino A; D'Angelo A; Ruggiero FG; Nocerino L; Auzino S; DAngelo M
    Recenti Prog Med; 1981 Feb; 70(2):160-75. PubMed ID: 6170099
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of the plasma defense systems in intensive care patients with and with without ARDS.
    Heller W; Fuhrer G; Junginger W
    Adv Exp Med Biol; 1989; 247A():615-20. PubMed ID: 2481392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Several components of plasma hemostasis in patients with suppurative processes in the abdominal cavity].
    Markova OA; Platonova TK; Khvatov VB
    Klin Med (Mosk); 1992 Feb; 70(2):91-3. PubMed ID: 1380586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The blood coagulation system in progressive systemic scleroderma].
    Sica S; Paoletti S; Storti S; Pagano L; Marra R; Garcovich A
    Minerva Med; 1987 Dec; 78(24):1831-4. PubMed ID: 2448705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.